ERBB2 and breast cancer: Significantly, the typical presentation of advanced stages at the time of diagnosis, along with more aggressive pathological features, a higher incidence of triple-negative and HER2-overexpressing tumors, increased rates of recurrence at any clinical stage, and inferior OS rates compared to older women, are the primary factors contributing to the ‘aggressive’ nature of BC in young women (11, 32).